Dermata Therapeutics Announces Strategic Pivot to Over-the-Counter Skin Care Treatments

Core Insights - Dermata Therapeutics, Inc. is shifting its strategic focus towards the development and distribution of over-the-counter (OTC) pharmaceutical dermatology products aimed at direct consumer sales [1] Company Strategy - The decision to pivot towards OTC products is based on insights gained from the development of the Company's Spongilla technology [1] - The strategic change is also influenced by current market dynamics, indicating a responsive approach to evolving consumer needs [1]